Ketogenic diet. Fatty (change of) liver, not elsewhere classified, Nonalcoholic fatty liver disease [NAFLD]
Conditions
Interventions
Intervention 1: Control group: A common diet (a low-calorie diet with moderate carbohydrates in which the share of carbohydrates is 55% of the total energy) is provided to the patients for 3 months. I
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients with Non-alcoholic fatty liver diseases Body mass index more than 25 kg/m2 Patient age between 20 and 60 years Not receiving the diet and exercise program in the past year
Exclusion criteria
Exclusion criteria: Suffering from chronic kidney diseases, heart diseases and other liver diseases (hepatitis, liver cirrhosis), diabetic patients treated with insulin Pregnancy or breastfeeding among female participants Unwillingness to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alanine transaminase. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Blood test, Hitachi 912 biochemical machine.;Aspartate aminotransferase. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Blood test, Hitachi 912 biochemical machine.;Low-density lipoprotein. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Blood test, Hitachi 912 biochemical machine.;High-density lipoprotein. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Blood test, Hitachi 912 biochemical machine.;Triglycerides. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Blood test, Hitachi 912 biochemical machine.;Blood Bilirubin. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Laboratory sample? Malloy_evelyn method.;Fatty liver grade. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Ultrasonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehran Ebrahimi
Qazvin University of Medical Sciences
Outcome results
None listed